Zhejiang Leapmotor Technology Co., Ltd. (HKG:9863)
Hong Kong · Delayed Price · Currency is HKD 58.40
-2.25 (-3.71%)
Aug 1, 2025, 4:08 PM HKT
Sage Therapeutics Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| 32,164 | 16,747 | 12,385 | 3,132 | 631.3 | Upgrade | |
Revenue Growth (YoY) | 92.06% | 35.22% | 295.41% | 396.13% | 439.74% | Upgrade |
Cost of Revenue | 29,470 | 16,666 | 14,296 | 4,520 | 950.9 | Upgrade |
Gross Profit | 2,694 | 80.47 | -1,911 | -1,388 | -319.6 | Upgrade |
Selling, General & Admin | 3,275 | 2,653 | 1,956 | 826.17 | 338.73 | Upgrade |
Research & Development | 2,896 | 1,920 | 1,411 | 740.02 | 289.25 | Upgrade |
Other Operating Expenses | -171.67 | -89.69 | -81.24 | -64.31 | -66.2 | Upgrade |
Operating Expenses | 6,004 | 4,483 | 3,286 | 1,502 | 561.92 | Upgrade |
Operating Income | -3,310 | -4,402 | -5,198 | -2,890 | -881.52 | Upgrade |
Interest Expense | -39.53 | -72.22 | -37.01 | -61.66 | -230.33 | Upgrade |
Interest & Investment Income | 348.18 | 229.36 | 143.27 | 84.01 | 1.29 | Upgrade |
Earnings From Equity Investments | 41.71 | 4.09 | 11.71 | 0.2 | -1.53 | Upgrade |
Currency Exchange Gain (Loss) | -3.65 | -18.2 | -52.39 | -0.09 | -0.04 | Upgrade |
Other Non Operating Income (Expenses) | -0.47 | 0.15 | -0.66 | 0.04 | -0.06 | Upgrade |
EBT Excluding Unusual Items | -2,964 | -4,259 | -5,133 | -2,867 | -1,112 | Upgrade |
Gain (Loss) on Sale of Investments | 186.76 | 43.69 | 21.69 | 22.24 | 1.96 | Upgrade |
Gain (Loss) on Sale of Assets | -43.82 | -0.6 | 2.1 | -0.67 | 10.14 | Upgrade |
Pretax Income | -2,821 | -4,216 | -5,109 | -2,846 | -1,100 | Upgrade |
Income Tax Expense | 0.08 | 0.08 | 0.05 | - | - | Upgrade |
Net Income | -2,821 | -4,216 | -5,109 | -2,846 | -1,100 | Upgrade |
Net Income to Common | -2,821 | -4,216 | -5,109 | -2,846 | -1,100 | Upgrade |
Shares Outstanding (Basic) | 1,337 | 1,165 | 1,045 | 940 | 368 | Upgrade |
Shares Outstanding (Diluted) | 1,337 | 1,165 | 1,045 | 940 | 368 | Upgrade |
Shares Change (YoY) | 14.81% | 11.42% | 11.18% | 155.69% | 0.13% | Upgrade |
EPS (Basic) | -2.11 | -3.62 | -4.89 | -3.03 | -2.99 | Upgrade |
EPS (Diluted) | -2.11 | -3.62 | -4.89 | -3.03 | -2.99 | Upgrade |
Free Cash Flow | 6,371 | -224.82 | -3,770 | -1,710 | -1,038 | Upgrade |
Free Cash Flow Per Share | 4.76 | -0.19 | -3.61 | -1.82 | -2.82 | Upgrade |
Gross Margin | 8.38% | 0.48% | -15.43% | -44.30% | -50.63% | Upgrade |
Operating Margin | -10.29% | -26.29% | -41.97% | -92.27% | -139.64% | Upgrade |
Profit Margin | -8.77% | -25.18% | -41.25% | -90.86% | -174.26% | Upgrade |
Free Cash Flow Margin | 19.81% | -1.34% | -30.45% | -54.59% | -164.45% | Upgrade |
EBITDA | -2,789 | -3,967 | -4,934 | -2,710 | -729.67 | Upgrade |
EBITDA Margin | -8.67% | -23.69% | -39.84% | -86.51% | -115.58% | Upgrade |
D&A For EBITDA | 521.04 | 435.69 | 263.3 | 180.18 | 151.85 | Upgrade |
EBIT | -3,310 | -4,402 | -5,198 | -2,890 | -881.52 | Upgrade |
EBIT Margin | -10.29% | -26.29% | -41.97% | -92.27% | -139.64% | Upgrade |
Advertising Expenses | 1,288 | 1,018 | 638.61 | 256.27 | 91.17 | Upgrade |
Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.